Literature DB >> 8548460

A canonical structure for the ligand-binding domain of nuclear receptors.

J M Wurtz1, W Bourguet, J P Renaud, V Vivat, P Chambon, D Moras, H Gronemeyer.   

Abstract

The ability of nuclear receptors (NRs) to activate transcription of target genes requires the binding of cognate ligands to their ligand-binding domains (LBDs). Information provided by the three-dimensional structures of the unliganded RXR alpha and the liganded RAR gamma LBDs has been incorporated into a general alignment of the LBDs of all NRs. A twenty amino-acid region constitutes a NR-specific signature and contains most of the conserved residues that stabilize the core of the canonical fold of NR LBDs. A common ligand-binding pocket, involving predominantly hydrophobic residues, is inferred by homology modelling of the human RXR alpha and glucocorticoid receptor ligand-binding sites according to the RAR gamma holo-LBD structure. Mutant studies support these models, as well as a general mechanism for ligand-induced activation deduced from the comparison of the transcriptionally active RAR gamma holo- and inactive RXR alpha apo-LBD structures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8548460     DOI: 10.1038/nsb0196-87

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  154 in total

1.  Large-scale expression and purification of the human vitamin D receptor and its ligand-binding domain for structural studies.

Authors:  K Juntunen; N Rochel; D Moras; P Vihko
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Rational discovery of novel nuclear hormone receptor antagonists.

Authors:  M Schapira; B M Raaka; H H Samuels; R Abagyan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Mechanism of corepressor binding and release from nuclear hormone receptors.

Authors:  L Nagy; H Y Kao; J D Love; C Li; E Banayo; J T Gooch; V Krishna; K Chatterjee; R M Evans; J W Schwabe
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

4.  Molecular determinants of nuclear receptor-corepressor interaction.

Authors:  V Perissi; L M Staszewski; E M McInerney; R Kurokawa; A Krones; D W Rose; M H Lambert; M V Milburn; C K Glass; M G Rosenfeld
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

5.  Molecular determinants of the estrogen receptor-coactivator interface.

Authors:  H Y Mak; S Hoare; P M Henttu; M G Parker
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation.

Authors:  D Li; F Wang; H H Samuels
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

7.  X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation.

Authors:  C Stehlin; J M Wurtz; A Steinmetz; E Greiner; R Schüle; D Moras; J P Renaud
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

8.  Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.

Authors:  D L Osburn; G Shao; H M Seidel; I G Schulman
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

9.  Mass-spectrometric analysis of agonist-induced retinoic acid receptor gamma conformational change.

Authors:  Valerie J Peterson; Elisabeth Barofsky; Max L Deinzer; Marcia I Dawson; Kai-Chia Feng; Xiao-kun Zhang; Machender R Madduru; Mark Leid
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

10.  A dominant negative PPARgamma mutant shows altered cofactor recruitment and inhibits adipogenesis in 3T3-L1 cells.

Authors:  Y Park; B D Freedman; E J Lee; S Park; J L Jameson
Journal:  Diabetologia       Date:  2003-03-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.